2496 — Wuhan YZY Biopharma Co Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeSmall CapSucker Stock

Annual balance sheet for Wuhan YZY Biopharma Co, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—
Source:	PROSPECTUS	PRESS	PRESS
Standards:	IFRS	—	—
Status:	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	103	201	197
Net Total Receivables	0.328	0	16
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	126	239	250
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	60.1	54.7	50.5
Long Term Investments
Long Term Notes Receivable
Total Assets	200	303	302
Accounts Payable
Payable / Accrued
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	56.9	147	174
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	57	147	174
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Total Equity	143	156	128
Total Liabilities & Shareholders' Equity	200	303	302
Total Common Shares Outstanding